Merck & Company Inc - Stock Based Compensation

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.

The item "Stock-Based-Compensation" stands at 802.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Merck & Company Inc's third quarter result of 204.00 Million USD for the item "Stock Based Compensation" represents a decrease of -5.56 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 204.00 Million USD for the item "Stock Based Compensation" represents an increase of 4.62 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 802.00 Million USD for the item "Stock Based Compensation" represents an increase of 1.13 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.23 percent compared to the value the year prior.
The 1 year change in percent is 8.23.
The 3 year change in percent is 55.73.
The 5 year change in percent is 82.27.
The 10 year change in percent is 176.55.

The Serie's long term average value is 426.45 Million United States Dollars. It's latest available value, on 09/30/2025, is 88.07 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2014, to it's latest available value, on 09/30/2025, is +202.64%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.